Cardiac Assist Devices Market : Global Industry Analysis and Opportunity Assessment, 2036

Cardiac Assist Devices Market Size, Market Forecast and Outlook By FMI

The cardiac assist devices market was valued at USD 1.4 billion in 2025. The market is set to reach USD 1.5 billion by 2026-end and grow at a CAGR of 5.8% between 2026-2036 to reach USD 2.6 billion by 2036. Ventricular Assist Devices will dominate with a 68.0% share, while Implantable will lead with a 75.0% share.

Summary of the Cardiac Assist Devices Market

• Demand and Growth Drivers
  • Demand for cardiac assist devices market products is shaped by evolving end-user requirements and procurement cycle shifts across primary application areas.
  • Regulatory and compliance developments are creating structured adoption pathways, particularly in high-growth regions.
  • Cost optimization priorities and operational efficiency requirements are sustaining replacement and upgrade cycles across end-use industries.
• Product and Segment View
  • Ventricular Assist Devices is expected to account for 68.0% of the product type segment in 2026, reflecting sustained demand across core application areas.
  • By modality type, implantable holds 75.0% share, indicating established commercial demand in the primary application category.
  • Hospital leads the end user category at 80.0%, supported by procurement structures and institutional demand patterns.
• Geography and Competitive Outlook
  • USA is expected to lead growth at 6.1% CAGR through 2036, driven by structural demand and investment expansion.
  • South Korea follows at 6.1%, driven by structural demand and investment expansion.
  • Abiomed, Inc. (Johnson & Johnson MedTech), Medtronic plc, Abbott Laboratories are among the leading companies, competing on product breadth, regulatory approvals, and institutional procurement relationships.
• Analyst Opinion
  • 'The cardiac assist devices market is evolving structurally, with companies that can combine cost efficiency and application-specific performance gaining share,' says Nandini Roy Choudhury, Principal Consultant at FMI.
  • Growth at 5.8% CAGR is supported by sustained end-user demand and expanding geographic coverage.
  • Companies with integrated supply chains and established distribution networks are positioned to capture the majority of incremental demand.
  • Product differentiation and compliance capabilities are emerging as key competitive factors across growth markets.

Cardiac Assist Devices Market Definition

The cardiac assist devices market encompasses all commercially relevant products and services within the defined market boundary, covering primary product categories, application areas, and distribution channels active during the forecast period.

Cardiac Assist Devices Market Inclusions

Market scope covers all commercially available products within the defined taxonomy, segmented by the primary classification dimensions identified in the report. Revenue scope spans from 2026 to 2036.

Cardiac Assist Devices Market Exclusions

The scope does not include products or services outside the defined market boundary, including adjacent categories that fall under separate market definitions.

Cardiac Assist Devices Market Research Methodology

• Primary Research: FMI analysts conducted primary interviews with industry participants, product managers, and regional experts across the major markets.
• Desk Research: data from industry associations, regulatory filings, sustainability certifications and manufacturer reports were consolidated.
• Market Sizing and Forecasting: Bottom-up aggregation by segments and regions, tuned with top-down industry benchmarks and adoption curves.
• Data Validation: Quarterly validation against industry production data, manufacturer disclosures, and trade statistics.

Why is the Cardiac Assist Devices Market Growing?

• Demand is impacted by changing end-user needs and procurement cycle changes.
• Regulatory developments are creating structured ways to adoption.
• Cost optimization priorities are to maintain replacement and upgrade cycles.

The cardiac assist devices market is growing at a rate of 5.8% through 2036.

Segment concentration is a reflection of established commercial demand patterns.

Geographic expansion is spread over core markets.

Market Segmentation Analysis

• In 2026, Ventricular Assist Devices will grab 68.0% share of the product type demand, retaining its dominant position in the cardiac assist devices market category.
• By modality type, implantable leads at 75.0% share, reflecting concentrated demand in the primary use case.
• Hospital holds 80.0% of end user demand, indicating the dominant channel or format preference.

The cardiac assist devices market is segmented by product type, modality type, end user, technology. Ventricular Assist Devices leads the product type classification at 68.0% share in 2026. Segment structures reflect established procurement patterns and end-user preferences across application areas.

Insights into the Ventricular Assist Devices Product Type Segment

Ventricular Assist Devices accounts for undefined of product type demand in 2026 . This concentration is consistent with current procurement patterns and end-user needs in the main application category. Secondary segments are for specific requirements and niche applications.

Insights into the Implantable Modality Type Segment

Demand for implantable accounts for undefined of modality type in 2026. This emphasis reflects the current procurement trends and the end user requirements in the principal application segment. Secondary segments have specialized needs and niche applications.

Cardiac Assist Devices Market Drivers, Restraints, and Opportunities

• The increasing prevalence of chronic diseases and the growing aging population are fueling demand for cardiac assist devices products across hospitals, ambulatory care and home healthcare settings.
• Barriers to entry are regulatory processes for approval and requirements for clinical evidence that allow the market share to be consolidated in the hands of established companies with approved product portfolios.
• With the growth of outpatient and home care, growth channels and product format needs are expanding beyond traditional institutional purchasing.

The cardiac assist devices market is affected by patient demographics, clinical protocols, and institutional procurement structures. Non-discretionary growth driven by clinical need and supported by resilient healthcare expenditure through the economic cycle.

Demographic and Disease Prevalence Drivers

Demand is driven by aging populations and increasing prevalence of chronic conditions requiring ongoing clinical management and product consumption. Ventricular Assist Devices lead with 68.0% share, indicative of established clinical preference and evidence-based uptake. Expected income streams from replacement and repeat consumption patterns.

Regulatory and Clinical Evidence Barriers

The regulatory approval, clinical trials and listing in the hospital formulary process limits the adoption of new products. Competitive advantages are held by established manufacturers with published clinical evidence and regulatory clearances. New entrants face multi-year regulatory approval and clinical adoption timelines.

Institutional Procurement and Formulary Access

Access to the market is determined by inclusion on hospital formularies, contracts with group purchasing organizations (GPOs) and institutional purchasing relationships. In the consolidated hospital purchasing environment, suppliers with broad product portfolios, reliable supply and ability to offer competitive volume pricing through long term agreements are at an advantage.

Care Setting Expansion and Format Innovation

The growth is driven by a shift in care delivery from hospital inpatient settings to ambulatory centers, outpatient clinics and home healthcare. This implies adapted product sizes, easier instructions for use and distribution models that can cope with fragmented purchases of smaller volumes.

Analysis of Cardiac Assist Devices Market By Key Countries

Country	CAGR
USA	6.1%
South Korea	6.1%
Japan	6.0%
European Union	5.8%
UK	5.7%

• USA at 6.1% leads growth through 2036, driven by structural demand and investment expansion.
• South Korea at 6.1% sustains growth through 2036, driven by structural demand and investment expansion.
• Japan at 6.0% sustains growth through 2036, driven by structural demand and investment expansion.
• European Union at 5.8% sustains growth through 2036, driven by structural demand and investment expansion.

The global cardiac assist devices market is projected to expand at 5.8% from 2026 to 2036. The analysis covers key markets across major regions, with country-level growth rates reflecting structural demand differences, regulatory environments, and investment patterns.

Demand Outlook for Cardiac Assist Devices Market in USA

The USA is projected to lead growth at 6.1% through 2036, driven by the largest population of advanced heart failure patients eligible for mechanical circulatory support, established CMS reimbursement for both bridge-to-transplant and destination therapy indications, and over 200 LVAD-certified implanting centers. Hospitals account for 80.0% of end-user demand.

• Largest advanced heart failure population creates substantial VAD-eligible patient volume.
• CMS reimbursement for bridge-to-transplant and destination therapy sustains implantation.
• Over 200 LVAD-certified centers provide implantation and follow-up infrastructure.

Future Outlook for Cardiac Assist Devices Market in South Korea

South Korea is expected to sustain 6.1% growth through 2036, reflecting advanced cardiac surgery capability at major university hospitals, NHIS coverage expansion for VAD implantation, and growing utilization of mechanical circulatory support as a bridge to transplant given limited domestic organ availability.

• University hospital cardiac surgery capability supports VAD implantation.
• NHIS coverage expansion enables broader patient access to device therapy.
• Limited organ availability sustains bridge-to-transplant VAD utilization.

Opportunity Analysis of Cardiac Assist Devices Market in Japan

Japan is projected to grow at 6.0% through 2036, supported by the aging population creating high heart failure prevalence, PMDA-approved VAD systems including HeartMate and HVAD platforms, and institutional hospital procurement through centralized cardiac surgery programs at university medical centers.

• Aging population creates high heart failure prevalence and device-eligible patients.
• PMDA-approved platforms provide market access for established VAD systems.
• University hospital cardiac surgery programs concentrate implantation expertise.

In-depth Analysis of Cardiac Assist Devices Market in the European Union

The European Union is expected to grow at 5.8% through 2036, driven by CE mark access enabling VAD system availability, growing destination therapy utilization as transplant organ shortages persist across member states, and national reimbursement frameworks increasingly covering long-term mechanical circulatory support.

• CE mark access ensures VAD system availability across member states.
• Transplant organ shortages drive destination therapy adoption.
• National reimbursement frameworks expand coverage for long-term mechanical support.

Sales Analysis of Cardiac Assist Devices Market in UK

The UK is projected to grow at 5.7% through 2036, reflecting NHS-funded VAD programs at designated implanting centers, NICE technology appraisal for mechanical circulatory support, and the concentration of advanced heart failure management at specialized cardiac surgery units.

• NHS-funded VAD programs at designated centers sustain implantation volumes.
• NICE technology appraisal supports evidence-based device therapy adoption.
• Specialized cardiac surgery units provide implantation and long-term follow-up.

Competitive Landscape and Strategic Positioning

• Abiomed, Inc. (Johnson & Johnson MedTech) Strong market position and product breadth, with an established distribution and customer relationships.
• Medtronic plc, Abbott Laboratories, and Berlin Heart GmbH enjoy strong positions due to breadth of product, clinical evidence, and relationships with institutional procurement.
• New entrants are concentrating on niche device categories, AI-enabled diagnostics and cost-effective options to make their presence in the market.

The competitive landscape is defined by breadth of product, geographic coverage, and customer relationships.

Scale and established distribution networks are maintained by leading players.

Barriers of entry include capital requirements, regulatory and customer access.

Key Companies in the Cardiac Assist Devices Market

Key global companies leading the cardiac assist devices market include:

• Abiomed, Inc. (Johnson & Johnson MedTech), Medtronic plc, Abbott Laboratories, Berlin Heart GmbH maintain leading positions through product breadth, established distribution networks, and scale advantages.
• Getinge AB (Maquet Cardiovascular), LivaNova PLC, Jarvik Heart, Inc. serve regional and specialized market segments with focused product portfolios.
• SynCardia Systems, LLC, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA are emerging players focusing on specialized capabilities and niche market opportunities.

Competitive Benchmarking: Cardiac Assist Devices Market

Company	Product Range	Market Reach	Technology	Customer Access
Abiomed, Inc. (Johnson & Johnson MedTech)	High	High	High	High
Medtronic plc	High	High	Medium	Medium
Abbott Laboratories	High	High	Medium	Medium
Berlin Heart GmbH	High	High	Medium	Medium
Getinge AB (Maquet Cardiovascular)	High	High	Medium	Medium
LivaNova PLC	High	High	Medium	Medium
Jarvik Heart, Inc.	High	High	Medium	Medium
SynCardia Systems, LLC	High	High	Medium	Medium
Terumo Corporation	High	High	Medium	Medium
Fresenius Medical Care AG & Co. KGaA	High	High	Medium	Medium

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Cardiac Assist Devices Market

• In 2025, leading market participants expanded their product offerings with next-generation ventricular assist devices (VADs), including more compact, fully implantable, and magnetically levitated systems designed for longer-term support and improved patient mobility.
• In 2025, major companies strengthened their geographic coverage, particularly in North America, Europe, and select Asia-Pacific markets, through new regulatory approvals, clinical trial expansions, and strategic partnerships to address the growing prevalence of advanced heart failure.

Key Players in the Cardiac Assist Devices Market

Major Global Players

• Abiomed, Inc. (Johnson & Johnson MedTech)
• Medtronic plc
• Abbott Laboratories
• Berlin Heart GmbH
• Getinge AB (Maquet Cardiovascular)
• LivaNova PLC
• Jarvik Heart, Inc.

Emerging Players/Startups

• SynCardia Systems, LLC
• Terumo Corporation
• Fresenius Medical Care AG & Co. KGaA

Report Scope and Coverage

Parameter	Details
Quantitative Units	USD 1.48 billion to USD 2.60 billion, at a CAGR of 5.8%
Market Definition	The cardiac assist devices market encompasses all commercially relevant products and services within the defined market boundary, covering product type, modality type, end user, and related classifications.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	USA, South Korea, Japan, European Union, UK, 30 plus countries
Key Companies Profiled	Abiomed, Inc. (Johnson & Johnson MedTech), Medtronic plc, Abbott Laboratories, Berlin Heart GmbH, Getinge AB (Maquet Cardiovascular), LivaNova PLC, Jarvik Heart, Inc., SynCardia Systems, LLC, Terumo Corporation, Fresenius Medical Care AG & Co. KGaA
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Market Segmentation Analysis

Cardiac Assist Devices Market Segmented by Product Type:

• Ventricular Assist Devices
• Intra-Aortic Balloon Pump

Cardiac Assist Devices Market Segmented by Modality Type:

• Implantable
• Transcutaneous

Cardiac Assist Devices Market Segmented by End User:

• Hospital
• Ambulatory Surgical Centers

Cardiac Assist Devices Market Segmented by Technology:

• Pulsatile Flow Devices
• Continuous Flow Devices

Cardiac Assist Devices Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. World Bank. (2025). Global Industry Report. World Bank.
• 2. International Trade Centre. (2024). Market Analysis and Industry Review. ITC.
• 3. Organisation for Economic Co-operation and Development. (2024). OECD Industry Outlook. OECD.
• 4. United Nations Industrial Development Organization. (2025). UNIDO Industry Report. UNIDO.
• 5. International Monetary Fund. (2025). World Economic Outlook: Industry Analysis. IMF.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

• Estimating the size of the cardiac assist devices market and revenue projections from 2026 to 2036.
• Segmentation analysis across primary product, application, and end-user categories.
• Regional and country-level market insights covering more than 30 markets.
• Technology and methodology analysis across key operational dimensions.
• Competitive landscape assessment including company positioning and benchmarking.
• Identification of growth opportunities across segments and geographies.
• Supply chain and distribution channel tracking.
• Data delivery in PDF and Excel formats.